| 1 |
Accorsi P, Berti P, de Angelis V, et al; Italian Society for Transfusion Medicine Immunohaematology (SIMTI) Italian Society for Hemapheresis cell Manipulation (SIdEM). Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19 [J]. Transfus Apher Sci, 2020, 59(4): 102817.
|
| 2 |
Jouffroy R, Gilbert B, Tourtier JP, et al. Prehospital bundle of care based on antibiotic therapy and hemodynamic optimization is associated with a 30-day mortality decrease in patients with septic shock [J]. Crit Care Med, 2022, 50(10): 1440-1448.
|
| 3 |
Wang W, Liu CF. Sepsis heterogeneity [J]. World J Pediatr, 2023, 19(10): 919-927.
|
| 4 |
Wang HE, Shapiro NI, Griffin R, et al. Chronic medical conditions and risk of sepsis [J]. PLoS One, 2012, 7(10): e48307.
|
| 5 |
Alrawashdeh M, Klompas M, Simpson SQ, et al. Prevalence and outcomes of previously healthy adults among patients hospitalized with community-onset sepsis [J]. Chest, 2022, 162(1): 101-110.
|
| 6 |
Yang J, Yang L, Wang Y, et al. Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis [J]. Mol Med, 2025, 31(1): 34.
|
| 7 |
Zador Z, Landry A, Cusimano MD, et al. Multimorbidity states associated with higher mortality rates in organ dysfunction and sepsis: a data-driven analysis in critical care [J]. Crit Care, 2019, 23(1): 247.
|
| 8 |
Kang C, Choi S, Jang EJ, et al. Prevalence and outcomes of chronic comorbid conditions in patients with sepsis in Korea: a nationwide cohort study from 2011 to 2016 [J]. BMC Infect Dis, 2024, 24(1): 184.
|
| 9 |
Faust JS, Weingart SD. The past, present, and future of the centers for medicare and medicaid services quality measure SEP-1: the early management bundle for severe sepsis/septic shock [J]. Emerg Med Clin North Am, 2017, 35(1): 219-231.
|
| 10 |
Sloan S, Rodriguez N, Seward T, et al. Compliance with SEP-1 guidelines is associated with improved outcomes for septic shock but not for severe sepsis [J]. J Intensive Med, 2022, 2(3): 167-172.
|
| 11 |
Barbash IJ, Davis BS, Yabes JG, et al. Treatment patterns and clinical outcomes after the introduction of the medicare sepsis performance measure (SEP-1) [J]. Ann Intern Med, 2021, 174(7): 927-935.
|
| 12 |
Beagle AJ, Prasad PA, Hubbard CC, et al. Associations between volume of early intravenous fluid and hospital outcomes in septic patients with and without heart failure: a retrospective cohort study [J]. Crit Care Explor, 2024, 6(5): e1082.
|
| 13 |
Jia X, Zhang H, Sui W, et al. Association between average mean arterial pressure and 30-day mortality in critically ill patients with sepsis and primary hypertension: a retrospective analysis [J]. Sci Rep, 2024, 14(1): 20640.
|
| 14 |
Scheeren TWL, Bakker J, De Backer D, et al. Current use of vasopressors in septic shock [J]. Ann Intensive Care, 2019, 9(1): 20.
|
| 15 |
Endo A, Yamakawa K, Tagami T, et al. Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial [J]. Intensive Care Med, 2025, 51(5): 883-892.
|
| 16 |
张靖垚, 陈瑞, 童颖目, 等. 器官储备功能在脓毒症中的作用及应用 [J]. 中华消化外科杂志, 2022, 21(12): 1518-1523.
|
| 17 |
Kornev M, Caglayan HA, Kudryavtsev AV, et al. Influence of hypertension on systolic and diastolic left ventricular function including segmental strain and strain rate [J]. Echocardiography, 2023, 40(7): 623-633.
|
| 18 |
Wuthiwaropas P, Bellavia D, Omer M, et al. Impact of cardiac rehabilitation exercise program on left ventricular diastolic function in coronary artery disease: a pilot study [J]. Int J Cardiovasc Imaging, 2013, 29(4): 777-785.
|
| 19 |
Pagliaro BR, Cannata F, Stefanini GG, et al. Myocardial ischemia and coronary disease in heart failure [J]. Heart Fail Rev, 2020, 25(1): 53-65.
|
| 20 |
Kakihana Y, Ito T, Nakahara M, et al. Sepsis-induced myocardial dysfunction: pathophysiology and management [J]. J Intensive Care, 2016, 4: 22.
|
| 21 |
Wang J, Wang XT, Liu DW, et al. Induction and deduction in sepsis-induced cardiomyopathy: five typical categories [J]. Chin Med J (Engl), 2020, 133(18): 2205-2211.
|
| 22 |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease [J]. Lancet, 2022, 399(10342): 2227-2242.
|
| 23 |
Marchioni A, Tonelli R, Cerri S, et al. Pulmonary stretch and lung mechanotransduction: implications for progression in the fibrotic lung [J]. Int J Mol Sci, 2021, 22(12): 6443.
|
| 24 |
Wang F, Chen M, Ma J, et al. Integrating bulk and single-cell sequencing reveals the phenotype-associated cell subpopulations in sepsis-induced acute lung injury [J]. Front Immunol, 2022, 13: 981784.
|
| 25 |
Marongiu I, Slobod D, Leali M, et al. Clinical and experimental evidence for patient self-inflicted lung injury (P-SILI) and bedside monitoring [J]. J Clin Med, 2024, 13(14): 4018.
|
| 26 |
Chihara Y, Tsuboi T, Sumi K, et al. Effect of high fraction of inspired oxygen and high flow on exercise tolerance in patients with COPD and IPF: a randomized crossover trial [J]. Respir Investig, 2025, 63(3): 431-437.
|
| 27 |
Guo Y, Qiu Y, Xue T, et al. Association between admission baseline blood potassium levels and all-cause mortality in patients with acute kidney injury combined with sepsis: a retrospective cohort study [J]. PLoS One, 2024, 19(11): e0309764.
|
| 28 |
White KC, Bellomo R, Tabah A, et al. Sepsis-associated acute kidney injury in patients with chronic kidney disease: Patient characteristics, prevalence, timing, trajectory, treatment and associated outcomes [J]. Nephrology (Carlton), 2024, 29(12): 838-848.
|
| 29 |
Chen WY, Cai LH, Zhang ZH, et al. The timing of continuous renal replacement therapy initiation in sepsis-associated acute kidney injury in the intensive care unit: the CRTSAKI Study (Continuous RRT Timing in Sepsis-associated AKI in ICU): study protocol for a multicentre, randomised controlled trial [J]. BMJ Open, 2021, 11(2): e040718.
|
| 30 |
Jorda A, Douglas IS, Staudinger T, et al. Fluid management for sepsis-induced hypotension in patients with advanced chronic kidney disease: a secondary analysis of the CLOVERS trial [J]. Crit Care, 2024, 28(1): 231.
|
| 31 |
Jones TW, Smith SE, Van Tuyl JS, et al. Sepsis with preexisting heart failure: management of confounding clinical features [J]. J Intensive Care Med, 2021, 36(9): 989-1012.
|
| 32 |
Douglas IS, Alapat PM, Corl KA, et al. Fluid response evaluation in sepsis hypotension and shock: a rando mized clinical trial [J]. Chest, 2020, 158(4): 1431-1445.
|
| 33 |
Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy [J]. Ann Intensive Care, 2011, 1(1): 1.
|
| 34 |
Wang A, Zhang N, Li M, et al. Real-life experiences of self-capacity management in patients with chronic heart failure: a qualitative study [J]. Patient Prefer Adherence, 2025, 19: 1747-1762.
|
| 35 |
Jury D, Shaw AD. Utility of bedside ultrasound derived hepatic and renal parenchymal flow patterns to guide management of acute kidney injury [J]. Curr Opin Crit Care, 2021, 27(6): 587-592.
|
| 36 |
中国医疗保健国际交流促进会急诊医学分会, 中华医学会急诊医学分会, 国家老年医学中心, 等. 成人脓毒症相关心肌损伤和(或)心功能障碍: 急诊专家共识 [J]. 中国急救医学, 2025, 45(9): 737-747.
|
| 37 |
Li N, Fang D, Ge F, et al. Subphenotypic features of patients with sepsis and ARDS: a multicenter cohort study [J]. Front Med (Lausanne), 2024, 11: 1476512.
|
| 38 |
Yu J, Zheng R, Lin H, et al. Global end-diastolic volume index vs CVP goal-directed fluid resuscitation for COPD patients with septic shock: a randomized controlled trial [J]. Am J Emerg Med, 2017, 35(1): 101-105.
|
| 39 |
Li S, Zhao D, Cui J, et al. Prevalence, potential risk factors and mortality rates of acute respiratory distress syndrome in Chinese patients with sepsis [J]. J Int Med Res, 2020, 48(2): 300060519895659.
|
| 40 |
Vignon P, Evrard B, Asfar P, et al. Fluid administration and monitoring in ARDS: which management? [J]. Intensive Care Med, 2020, 46(12): 2252-2264.
|
| 41 |
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network; Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury [J]. N Engl J Med, 2006, 354(24): 2564-2575.
|
| 42 |
Yu X, Jiao Z, Yang F, et al. Construction and validation of an early warning model for predicting the 28-day mortality in sepsis patients with chronic obstructive pulmonary disease [J]. Int J Chron Obstruct Pulmon Dis, 2025, 20: 1373-1385.
|
| 43 |
Zhang J, Yan W, Dong Y, et al. Early identification and diagnosis, pathophysiology, and treatment of sepsis-related acute lung injury: a narrative review [J]. J Thorac Dis, 2024, 16(8): 5457-5476.
|
| 44 |
Liu AB, Tan B, Yang P, et al. The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential [J]. Front Immunol, 2024, 15: 1487576.
|
| 45 |
Rice DM, Ratliff PD, Judd WR, et al. Assessing the impact of CKD on outcomes in septic shock patients receiving standard Vs reduced initial fluid volume [J]. Am J Emerg Med, 2020, 38(10): 2147-2150.
|
| 46 |
Romagnoli S, Ricci Z, Ronco C. CRRT for sepsis-induced acute kidney injury [J]. Curr Opin Crit Care, 2018, 24(6): 483-492.
|
| 47 |
Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial [J]. JAMA, 2016, 315(20): 2190-2199.
|
| 48 |
Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H. Sepsis-associated acute kidney injury [J]. Crit Care Clin, 2021, 37(2): 279-301.
|
| 49 |
刘彩虹, Koyner J, 赵宇亮, 等. 《第28届急性疾病质量倡议工作组共识报告: 脓毒症相关急性肾损伤》解读 [J]. 中华肾脏病杂志, 2024, 40(3): 237-244.
|